Relay Therapeutics's total assets for Q4 2025 were $621.33M, a decrease of -7.26% from the previous quarter. RLAY total liabilities were $54.27M for the fiscal quarter, a -12.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.